Clinical Trials Sponsored by Novartis Pharmaceuticals
Total 21326 results
-
Novartis PharmaceuticalsCompletedPrimary Biliary CholangitisUnited States, Germany, Russian Federation, Canada, United Kingdom, Poland
-
Novartis PharmaceuticalsCompletedSeasonal Allergic RhinitisJapan
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Netherlands, United Kingdom
-
Novartis PharmaceuticalsCompletedLymphoma | Leukemia | Multiple MyelomaUnited States, Germany, Australia
-
Novartis PharmaceuticalsCompletedPulmonary Cystic FibrosisGermany, United States
-
Novartis PharmaceuticalsCompletedSporadic Inclusion Body Myositis (sIBM)United States
-
Novartis PharmaceuticalsTerminatedCystic FibrosisUnited States, Belgium, Germany, France, United Kingdom, Ireland, Romania
-
Novartis PharmaceuticalsTerminatedPeripheral Artery DiseaseUnited States, Germany, Jordan
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Novartis PharmaceuticalsCompletedHepatic ImpairmentHungary, Russian Federation
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerUnited States, Germany, Belgium, Italy, France, Canada, Hungary, Poland, Switzerland, Spain
-
Novartis PharmaceuticalsCompletedSchizophreniaUnited States
-
Novartis PharmaceuticalsTerminatedMajor Depressive DisorderUnited States, Puerto Rico
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedDyskinesias | Drug-inducedUnited States, France, Germany, Italy
-
Novartis PharmaceuticalsCompletedParkinson Disease | Parkinsonian Disorders | Movement Disorders | DyskinesiasSpain, France, Germany, Hungary, Italy, Canada, United States
-
Novartis PharmaceuticalsCompletedAsthmaRussian Federation, United Kingdom
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell CarcinomaChina
-
Novartis PharmaceuticalsCompletedAlcoholism | Hepatic CirrhosisGermany, Belgium, United States, South Africa
-
Novartis PharmaceuticalsCompletedBreast Cancer | Multiple MyelomaUnited States
-
Novartis PharmaceuticalsCompleted3rd Line GISTItaly, Belgium, Spain, Netherlands, Germany, United Kingdom, France, United States
-
Novartis PharmaceuticalsCompletedDyslipidemia | Healthy VolunteersUnited States
-
Novartis PharmaceuticalsCompletedHepatic InsufficiencyGermany, Russian Federation, Singapore
-
Novartis PharmaceuticalsTerminatedSolid Tumors for Phase Ib | Pancreatic Cancer for Phase II | Colorectal Cancer for Phase IIUnited States, Canada, Australia, Belgium, Germany, Netherlands, Spain
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerFrance, Canada, United States, Russian Federation, Denmark
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorsUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Melanoma and Merkel Cell CarcinomaGermany, Switzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
Novartis PharmaceuticalsCompletedExudative Macular Degeneration | Neovascular Age-elated Macular Degeneration (Wet AMD)United States
-
Novartis PharmaceuticalsCompletedOcular Hypertension | GlaucomaUnited States
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Hungary, Poland, Germany, France
-
Novartis PharmaceuticalsCompletedCystic FibrosisUnited States
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Taiwan, Germany, Italy, Hong Kong, Canada, Japan, Spain
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMetastatic MelanomaSwitzerland, United States
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorUnited States
-
Novartis PharmaceuticalsCompletedChronic Hepatitis C Genotype-1 RelapseBelgium, United States, Germany, Spain, Puerto Rico, Taiwan, Australia
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedCancer | Advanced Solid TumorJapan
-
Novartis PharmaceuticalsCompletedALK-positive Advanced TumorsItaly, Spain, Denmark, United States
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersSpain, Switzerland, United Kingdom, United States
-
Novartis PharmaceuticalsCompletedUrothelial CancerUnited States, Spain, Taiwan, Germany, Canada, United Kingdom, Italy, Austria
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States, Canada, Finland, France, Italy, Spain, Taiwan, United Kingdom
-
Novartis PharmaceuticalsCompletedcMET Dysegulation Advanced Solid TumorsAustria, Denmark, Sweden, United Kingdom, Spain, Germany, Netherlands, United States
-
Novartis PharmaceuticalsCompletedCD79 Mutant or ABC-subtype Diffuse Large B-Cell LymphomaTaiwan, Italy, Netherlands, Hong Kong, Germany, United States, Korea, Republic of, France
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedA Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid TumorsSolid TumorsSpain, Italy, United States, Canada
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML)Japan